Location History:
- Bernardsville, NJ (US) (1980 - 1984)
- Norwich, CT (US) (1988 - 1991)
- Killingworth, CT (US) (1994)
- Groton, CT (US) (1999 - 2001)
Company Filing History:
6 out of 539 
6 out of 4,459 
1 out of 233 Years Active: 1980-2001
Title: The Innovations of Frederick J. Ehrgott
Introduction
Frederick J. Ehrgott is a notable inventor based in Norwich, Connecticut, with a remarkable portfolio of 13 patents. His work primarily focuses on pharmaceutical innovations, particularly in the field of chronic inflammatory diseases.
Latest Patents
One of his latest inventions involves novel 3-substituted-2-oxindole derivatives. This invention relates to compounds that serve as inhibitors of prostaglandin H₂ synthase, 5-lipoxygenase, and interleukin-1 biosynthesis. The compounds are useful as analgesic, anti-inflammatory, and anti-arthritic agents in treating chronic inflammatory diseases. Additionally, the invention includes pharmaceutical compositions comprising these derivatives, methods for inhibiting the biosynthesis of interleukin-1, and processes for preparing the 3-substituted-2-oxindole derivatives.
Career Highlights
Ehrgott has had a distinguished career, working with prominent companies such as Hoechst Roussel Pharmaceuticals and Pfizer Corporation. His contributions to the pharmaceutical industry have significantly advanced the development of treatments for various inflammatory conditions.
Collaborations
Throughout his career, Ehrgott has collaborated with notable colleagues, including Gary R. Schulte and Carl J. Goddard. These partnerships have fostered innovation and enhanced the impact of his work in the pharmaceutical field.
Conclusion
Frederick J. Ehrgott's contributions to the field of pharmaceuticals through his innovative patents and collaborations have made a significant impact on the treatment of chronic inflammatory diseases. His work continues to inspire advancements in medical science.